Skip to main content

Table 5 Correlation between LunX mRNA in the peripheral blood and clinical factor in NSCLC patients

From: Diagnostic utility of LunXmRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer

Clinical factor

Positive cases/total cases

Sex

 

P value

0.461

Male

22/31 (71.0%)

Female

11/13 (84.6%)

Age

 

P value

0.425

≤ 60

7/11 (63.6%)

> 60

26/33 (78.8%)

Pathologic Type

 

P value

0.482

Squ

18/26 (69.2%)

Ade

13/16 (81.3%)

LCLC

2/2 (100%)

Pathologic Stage

 

P value

0.010

I

3/8 (37.5%)

II

5/8 (62.5%)

III

11/14 (78.6%)

IV

14/14 (100%)

  1. P values were calculated using χ2 test.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us